undamentalytics Newsletter

Basil Michelle L: insider trades

Officer at Haemonetics Corp. No open-market purchases and 17 sales not made under a pre-set plan, reported from March 8, 2018 to October 26, 2022.

What happened after Basil Michelle L’s sales?

After their sales, the shares moved −11.8% against the index over 12 months on average (a negative figure means selling was the right call); 41% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Basil Michelle L: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 17 +0.2% +3.0% 47% 5 0.54 0.62 No reliable evidence
Sales, 12 months after the report 17 −11.8% +7.8% 41% 5 −0.58 0.59 No reliable evidence
Sales, 12 months after the trade 17 −10.4% +7.8% 41% 5 −0.56 0.61 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Haemonetics Corp HAE EVP and General Counsel017March 8, 2018October 26, 2022

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
October 26, 2022October 24, 2022 HAE Sale $14,470 −2.8%−7.1%−6.2%
June 15, 2022June 13, 2022 HAE Sale $17,340 +23.5%+20.0%+14.9%
May 23, 2022May 19, 2022 HAE Sale $192,548 +21.1%+29.3%+29.4%
May 18, 2022May 16, 2022 HAE Sale $10,996 +18.2%+29.4%+43.0%
June 16, 2021June 14, 2021 HAE Sale $11,675 +3.0%+6.8%+16.7%
June 9, 2021June 7, 2021 HAE Sale $24,350 +6.1%+14.9%+16.9%
May 20, 2021May 19, 2021 HAE Sale $12,142 −1.0%+10.5%+7.8%
May 18, 2021May 17, 2021 HAE Sale $11,418 −3.5%+7.8%+3.5%
March 10, 2021March 8, 2021 HAE Sale $46,227 −58.8%−62.6%−61.6%
October 26, 2020October 23, 2020 HAE Sale $19,291 −5.0%−72.1%−66.7%
June 10, 2020June 8, 2020 HAE Sale $66,660 −7.4%−76.1%−73.2%
May 19, 2020May 15, 2020 HAE Sale $20,389 −34.3%−88.8%−90.7%
March 10, 2020March 9, 2020 HAE Sale $38,710 −24.2%−31.5%−21.8%
June 13, 2019June 12, 2019 HAE Sale $25,264 +7.1%−28.6%−25.3%
March 11, 2019March 7, 2019 HAE Sale $32,676 +19.1%+17.9%+12.5%
June 8, 2018June 7, 2018 HAE Sale $42,378 +16.0%+12.2%+9.6%
March 8, 2018March 6, 2018 HAE Sale $28,097 +27.0%+16.8%+14.0%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Basil Michelle L traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.